Literature DB >> 15614488

[Acinar cell carcinomas and pancreatoblastomas: related but not the same].

B Sipos1, G Klöppel.   

Abstract

Acinar cell carcinomas and pancreatoblastomas are malignant tumors of the pancreas, showing predominantly acinar differentiation characterized by the immunohistochemical expression of pancreatic enzymes. Histologically, they usually display acinar and/or solid patterns, but may occasionally also exhibit cystic structures. The key feature of pancreatoblastomas is the presence of squamoid corpuscles. Acinar cell carcinomas predominantly occur in adults, pancreatoblastomas in children. Both tumor types commonly show allelic losses on chromosome 11p and mutations in the APC/beta-catenin signaling pathway. Pancreatoblastomas, in contrast to acinar cell carcinomas, are potentially curable.

Entities:  

Mesh:

Year:  2005        PMID: 15614488     DOI: 10.1007/s00292-004-0732-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  15 in total

1.  Usefulness of beta-catenin immunostaining for the differential diagnosis of solid-pseudopapillary neoplasm of the pancreas.

Authors:  Yukichi Tanaka; Kenji Notohara; Keisuke Kato; Rieko Ijiri; Shigeo Nishimata; Tetsumi Miyake; Masaharu Fukunaga; Minoru Horisawa; Yukio Nakatani
Journal:  Am J Surg Pathol       Date:  2002-06       Impact factor: 6.394

Review 2.  Mixed exocrine-endocrine tumors of the pancreas.

Authors:  G Klöppel
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

3.  Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors.

Authors:  Kyle D Holen; David S Klimstra; Amanda Hummer; Mithat Gonen; Kevin Conlon; Murray Brennan; Leonard B Saltz
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

4.  Intraductal acinar cell carcinoma of the pancreas.

Authors:  A Fabre; A Sauvanet; J F Flejou; J Belghiti; L Palazzo; P Ruszniewski; P Ruzniewski; C Degott; B Terris
Journal:  Virchows Arch       Date:  2001-03       Impact factor: 4.064

5.  Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.

Authors:  Susan C Abraham; David S Klimstra; Robb E Wilentz; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; Tsung-Teh Wu; Ralph H Hruban
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Acinar cell cystadenoma of the pancreas: a new entity?

Authors:  Giuseppe Zamboni; Benoit Terris; Aldo Scarpa; Markus Kosmahl; Paola Capelli; David S Klimstra; Polly W Y Lam; Günter Klöppel
Journal:  Am J Surg Pathol       Date:  2002-06       Impact factor: 6.394

7.  Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.

Authors:  Susan C Abraham; Tsung-Teh Wu; Ralph H Hruban; Jae-Hyuk Lee; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; David S Klimstra
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

8.  Pancreatoblastoma in an adult: its separation from acinar cell carcinoma.

Authors:  A Hoorens; F Gebhard; K Kraft; N R Lemoine; G Klöppel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 9.  Diagnosis, treatment and outcome of pancreatoblastoma.

Authors:  A R Dhebri; S Connor; F Campbell; P Ghaneh; R Sutton; J P Neoptolemos
Journal:  Pancreatology       Date:  2004-07-14       Impact factor: 3.996

10.  Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.

Authors:  A Hoorens; N R Lemoine; E McLellan; T Morohoshi; T Kamisawa; P U Heitz; B Stamm; J Rüschoff; B Wiedenmann; G Klöppel
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more
  1 in total

Review 1.  [What is new in the pathology of pancreatic neuroendocrine tumors?].

Authors:  P Komminoth; A Perren
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.